Ovid Therapeutics Inc. (OVID) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 15 Form 4 transactions for Ovid Therapeutics Inc. (OVID) over the past 18 months (most recent 2026-04-09). Recent activity: PAPADOPOULOS STELIOS (Director) Buy 17,578 shares, Friedman Bart (Director) Buy 8,789 shares, Fitzgerald Kevin Joseph (Director) Buy 17,578 shares, LEVIN JEREMY M (Executive Chairman) Buy 47,333 shares, ALEXANDER MARGARET A. (President and CEO) Sell 11,656 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-04-09PAPADOPOULOS STELIOSDirectorBuy17,578$45,000
2026-04-09Friedman BartDirectorBuy8,789$22,500
2026-04-09Fitzgerald Kevin JosephDirectorBuy17,578$45,000
2026-03-25LEVIN JEREMY MExecutive ChairmanBuy47,333$66,266
2026-03-02ALEXANDER MARGARET A.President and CEOSell11,656$16,901
2026-03-02Rona Jeffrey ACBFOSell8,541$12,384
2026-03-02Rona Jeffrey ACBFOBuy68,125$0
2025-12-18LEVIN JEREMY MCEOBuy71,000$0
2025-12-09TAKEDA PHARMACEUTICAL CO LTDInsiderBuy1.2M$0
2025-12-09Takeda Pharmaceuticals U.S.A., Inc.InsiderBuy1.2M$0
2025-02-28Rona Jeffrey ACBFOSell3,902$2,185
2025-02-28ALEXANDER MARGARET A.President and COOSell5,279$2,956
2025-02-24Rona Jeffrey ACBFOBuy43,750$0
2025-02-24ALEXANDER MARGARET A.President and COOBuy43,750$0
2025-01-29ALEXANDER MARGARET A.President and COOBuy6,810$4,971

Source: SEC Form 4 filings · as of 2026-04-09